Clinical Trial Detail

NCT ID NCT03267498
Title Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

nasopharynx carcinoma

Therapies

Cisplatin + Nivolumab

Age Groups: senior adult

No variant requirements are available.